179 related articles for article (PubMed ID: 22705350)
1. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.
Gerard B; Sanders MA; Visscher DW; Tait L; Shekhar MP
Biochim Biophys Acta; 2012 Oct; 1823(10):1686-96. PubMed ID: 22705350
[TBL] [Abstract][Full Text] [Related]
2. Rad6B is a positive regulator of beta-catenin stabilization.
Shekhar MP; Gerard B; Pauley RJ; Williams BO; Tait L
Cancer Res; 2008 Mar; 68(6):1741-50. PubMed ID: 18339854
[TBL] [Abstract][Full Text] [Related]
3. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells.
Shekhar MP; Tait L; Gerard B
Mol Cancer Res; 2006 Oct; 4(10):729-45. PubMed ID: 17050667
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.
Sanders MA; Brahemi G; Nangia-Makker P; Balan V; Morelli M; Kothayer H; Westwell AD; Shekhar MPV
Mol Cancer Ther; 2013 Apr; 12(4):373-83. PubMed ID: 23339190
[TBL] [Abstract][Full Text] [Related]
5. Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target.
Gerard B; Tait L; Nangia-Makker P; Shekhar MP
J Mol Signal; 2011 Jul; 6():6. PubMed ID: 21767405
[TBL] [Abstract][Full Text] [Related]
6. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract][Full Text] [Related]
7. Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.
Gajan A; Martin CE; Kim S; Joshi M; Michelhaugh SK; Sloma I; Mittal S; Firestine S; Shekhar MPV
Cells; 2019 Nov; 8(11):. PubMed ID: 31683936
[TBL] [Abstract][Full Text] [Related]
8. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
[TBL] [Abstract][Full Text] [Related]
9. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Oncogene; 2004 Apr; 23(17):3097-106. PubMed ID: 14981545
[TBL] [Abstract][Full Text] [Related]
10. Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation.
Winer IS; Bommer GT; Gonik N; Fearon ER
J Biol Chem; 2006 Sep; 281(36):26181-7. PubMed ID: 16849322
[TBL] [Abstract][Full Text] [Related]
11. RNF168 forms a functional complex with RAD6 during the DNA damage response.
Liu C; Wang D; Wu J; Keller J; Ma T; Yu X
J Cell Sci; 2013 May; 126(Pt 9):2042-51. PubMed ID: 23525009
[TBL] [Abstract][Full Text] [Related]
12. Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis.
Pati D; Meistrich ML; Plon SE
Mol Cell Biol; 1999 Jul; 19(7):5001-13. PubMed ID: 10373550
[TBL] [Abstract][Full Text] [Related]
13. Ube2s stabilizes β-Catenin through K11-linked polyubiquitination to promote mesendoderm specification and colorectal cancer development.
Li Z; Wang Y; Li Y; Yin W; Mo L; Qian X; Zhang Y; Wang G; Bu F; Zhang Z; Ren X; Zhu B; Niu C; Xiao W; Zhang W
Cell Death Dis; 2018 May; 9(5):456. PubMed ID: 29674637
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
15. Interaction of PKCα with the armadillo repeats facilitates the N-terminal phosphorylation of β-catenin.
Gwak J; Yoo YS; Choi YJ; Oh S
Biochem Biophys Res Commun; 2014 Aug; 450(4):1673-8. PubMed ID: 25058461
[TBL] [Abstract][Full Text] [Related]
16. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Hoffmans R; Basler K
Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I.
Lei L; Bandola-Simon J; Roche PA
J Biol Chem; 2018 Mar; 293(11):3904-3912. PubMed ID: 29414787
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin conjugating enzyme E2 M promotes apoptosis in osteoarthritis chondrocytes via Wnt/β-catenin signaling.
Ba C; Ni X; Yu J; Zou G; Zhu H
Biochem Biophys Res Commun; 2020 Sep; 529(4):970-976. PubMed ID: 32819607
[TBL] [Abstract][Full Text] [Related]
19. Monoubiquitination of histone H2B is intrinsic to the Bre1 RING domain-Rad6 interaction and augmented by a second Rad6-binding site on Bre1.
Turco E; Gallego LD; Schneider M; Köhler A
J Biol Chem; 2015 Feb; 290(9):5298-310. PubMed ID: 25548288
[TBL] [Abstract][Full Text] [Related]
20. Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination.
DiBello A; Datta AB; Zhang X; Wolberger C
J Mol Biol; 2016 Nov; 428(23):4639-4650. PubMed ID: 27678051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]